164 related articles for article (PubMed ID: 11407449)
1. The dilemma of follow-up in head and neck cancer patients.
Haas I; Hauser U; Ganzer U
Eur Arch Otorhinolaryngol; 2001 May; 258(4):177-83. PubMed ID: 11407449
[TBL] [Abstract][Full Text] [Related]
2. [Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
Di Martino E; Hausmann R; Krombach GA; Nowak B; Tietze L; Gagel B; Zimny M; Westhofen M
Laryngorhinootologie; 2002 Dec; 81(12):866-74. PubMed ID: 12486624
[TBL] [Abstract][Full Text] [Related]
3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
4. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience.
Lavertu P; Adelstein DJ; Saxton JP; Secic M; Eliachar I; Strome M; Larto MA; Wood BG
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):142-8. PubMed ID: 10037279
[TBL] [Abstract][Full Text] [Related]
5. Unresectable primary and recurrent head and neck tumors: effect of hyperthermia and carboplatin--preliminary experience.
Chang P; Sapozink MD; Grunberg SM; Jozsef G; Rice DM; Formenti SC; Streeter OE
Radiology; 2000 Mar; 214(3):688-92. PubMed ID: 10715031
[TBL] [Abstract][Full Text] [Related]
6. Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.
Dornoff N; Weiß C; Rödel F; Wagenblast J; Ghanaati S; Atefeh N; Rödel C; Balermpas P
Strahlenther Onkol; 2015 Aug; 191(8):656-64. PubMed ID: 26004121
[TBL] [Abstract][Full Text] [Related]
7. Outcome of observing the N0 neck using ultrasonographic-guided cytology for follow-up.
van den Brekel MW; Castelijns JA; Reitsma LC; Leemans CR; van der Waal I; Snow GB
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):153-6. PubMed ID: 10037281
[TBL] [Abstract][Full Text] [Related]
8. Survival After Distant Metastasis in Head and Neck Cancer.
Wiegand S; Zimmermann A; Wilhelm T; Werner JA
Anticancer Res; 2015 Oct; 35(10):5499-502. PubMed ID: 26408715
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
Takácsi-Nagy Z; Hitre E; Remenár É; Oberna F; Polgár C; Major T; Gödény M; Fodor J; Kásler M
Strahlenther Onkol; 2015 Aug; 191(8):635-41. PubMed ID: 25782685
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic selective neck dissection: a 25-year review.
Muzaffar K
Laryngoscope; 2003 Sep; 113(9):1460-5. PubMed ID: 12972914
[TBL] [Abstract][Full Text] [Related]
11. [Tumor after-care: goals, results and concepts].
Haas I
Laryngorhinootologie; 2000 Nov; 79(11):667-8. PubMed ID: 11138508
[No Abstract] [Full Text] [Related]
12. [Current therapy options in recurrent head and neck cancer].
Boehm A; Wichmann G; Mozet C; Dietz A
HNO; 2010 Aug; 58(8):762-9. PubMed ID: 20628714
[TBL] [Abstract][Full Text] [Related]
13. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?
Narayan K; Crane CH; Kleid S; Hughes PG; Peters LJ
Head Neck; 1999 Oct; 21(7):606-13. PubMed ID: 10487947
[TBL] [Abstract][Full Text] [Related]
14. [Lymph node metastasis in head-neck tumors].
Remmert S; Rottmann M; Reichenbach M; Sommer K; Friedrich HJ
Laryngorhinootologie; 2001 Jan; 80(1):27-35. PubMed ID: 11272244
[TBL] [Abstract][Full Text] [Related]
15. Selective neck dissection as a therapeutic option in management of squamous cell carcinoma of unknown primary.
Dragan AD; Nixon IJ; Guerrero-Urbano MT; Oakley R; Jeannon JP; Simo R
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1249-56. PubMed ID: 23892690
[TBL] [Abstract][Full Text] [Related]
16. Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.
Onbasi Y; Lettmaier S; Hecht M; Semrau S; Iro H; Kesting M; Fietkau R; Haderlein M
Strahlenther Onkol; 2019 Jun; 195(6):482-495. PubMed ID: 30610355
[TBL] [Abstract][Full Text] [Related]
17. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
18. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and therapeutic pathways in head and neck cancers].
Dubois M; Ballivet de Régloix S; Raynal M; Lepage P; Kossowski M; Pons Y
Rev Laryngol Otol Rhinol (Bord); 2013; 134(2):81-8. PubMed ID: 24683817
[TBL] [Abstract][Full Text] [Related]
20. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
